DK1667960T3 - Meldoniumsalte, fremgangsmåde til deres fremstilling og farmaceutisk sammensætning på deres basis - Google Patents

Meldoniumsalte, fremgangsmåde til deres fremstilling og farmaceutisk sammensætning på deres basis

Info

Publication number
DK1667960T3
DK1667960T3 DK04748553T DK04748553T DK1667960T3 DK 1667960 T3 DK1667960 T3 DK 1667960T3 DK 04748553 T DK04748553 T DK 04748553T DK 04748553 T DK04748553 T DK 04748553T DK 1667960 T3 DK1667960 T3 DK 1667960T3
Authority
DK
Denmark
Prior art keywords
salts
sup
acid
meldonium
basis
Prior art date
Application number
DK04748553T
Other languages
Danish (da)
English (en)
Inventor
Ivars Kalvinsh
Anatolijs Birmans
Original Assignee
Grindeks Jsc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from LV030088A external-priority patent/LV13280B/lv
Priority claimed from LV030087A external-priority patent/LV13279B/lv
Application filed by Grindeks Jsc filed Critical Grindeks Jsc
Application granted granted Critical
Publication of DK1667960T3 publication Critical patent/DK1667960T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/10Hydrazines
    • C07C243/12Hydrazines having nitrogen atoms of hydrazine groups bound to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0031Rectum, anus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/10Hydrazines
    • C07C243/12Hydrazines having nitrogen atoms of hydrazine groups bound to acyclic carbon atoms
    • C07C243/14Hydrazines having nitrogen atoms of hydrazine groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/15Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing halogen
    • C07C53/16Halogenated acetic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02Dicarboxylic acids
    • C07C55/06Oxalic acid
    • C07C55/07Salts thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02Dicarboxylic acids
    • C07C55/10Succinic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02Dicarboxylic acids
    • C07C55/14Adipic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13Dicarboxylic acids
    • C07C57/145Maleic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13Dicarboxylic acids
    • C07C57/15Fumaric acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • C07C59/08Lactic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235Saturated compounds containing more than one carboxyl group
    • C07C59/245Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265Citric acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK04748553T 2003-08-04 2004-07-15 Meldoniumsalte, fremgangsmåde til deres fremstilling og farmaceutisk sammensætning på deres basis DK1667960T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
LV030088A LV13280B (en) 2003-08-04 2003-08-04 Sustained release salts of 3-(2,2,2-trimethylhydrazinium)propionate, a method of production and pharmaceutical compositions thereof
LV030087A LV13279B (en) 2003-08-04 2003-08-04 Non-hygroscopic salts of 3-(2,2,2-trimethylhydrazinum)propionate,a method of production and pharmaceutical compositions thereof
PCT/LV2004/000005 WO2005012233A1 (fr) 2003-08-04 2004-07-15 Sels de meldonium, leur procede de preparation et compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
DK1667960T3 true DK1667960T3 (da) 2008-06-09

Family

ID=34118016

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04748553T DK1667960T3 (da) 2003-08-04 2004-07-15 Meldoniumsalte, fremgangsmåde til deres fremstilling og farmaceutisk sammensætning på deres basis

Country Status (23)

Country Link
US (1) US7223797B2 (fr)
EP (1) EP1667960B1 (fr)
JP (1) JP4634380B2 (fr)
KR (1) KR100745160B1 (fr)
AT (1) ATE386014T1 (fr)
AU (1) AU2004260779B2 (fr)
CA (1) CA2535150C (fr)
DE (1) DE602004011790T2 (fr)
DK (1) DK1667960T3 (fr)
EA (1) EA009083B1 (fr)
ES (1) ES2302011T3 (fr)
HK (1) HK1093197A1 (fr)
HR (1) HRP20080192T3 (fr)
IL (1) IL173126A (fr)
MA (1) MA28025A1 (fr)
MX (1) MXPA06000955A (fr)
NO (1) NO334623B1 (fr)
NZ (1) NZ545440A (fr)
PL (1) PL1667960T3 (fr)
PT (1) PT1667960E (fr)
SI (1) SI1667960T1 (fr)
UA (1) UA82540C2 (fr)
WO (1) WO2005012233A1 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LV13450B (en) * 2004-08-24 2006-11-20 Grindeks As Novel medicinal use of meldonium and pharmaceutical compositions thereof
US10183001B1 (en) * 2007-05-22 2019-01-22 Pisgah Laboratories, Inc. Opioid and attention deficit hyperactivity disorder medications possessing abuse deterrent and anti-dose dumping safety features
TW200930356A (en) * 2007-12-04 2009-07-16 Grindeks Jsc New medical use of 3-(2,2,2-trimethylhydrazinium) propionate salts
EP2067474A1 (fr) 2007-12-05 2009-06-10 Grindeks, a joint stock company Nouvelle utilisation médicale de sel propionate 3-(2,2,2-trimethylhydrazinium)
TWI391131B (zh) * 2007-12-05 2013-04-01 Grindeks Jsc 3-(2,2,2-三甲基肼)丙酸鹽的新用途
ES2364017T3 (es) 2007-12-05 2011-08-23 Grindeks, A Joint Stock Company Sales de propionato de 3-(2,2,2-trimethylhydrazinium) para el tratamiento del infarto de miocardio.
EP2070529B1 (fr) 2007-12-12 2011-10-12 Grindeks, a joint stock company Utilisation médicale d'orotate propionate 3-(2,2,2-trimethylhydrazinium)
WO2009095445A1 (fr) * 2008-01-29 2009-08-06 Grindeks Nouvelle seconde utilisation médicale de 3-(2,2,2-triméthylhydrazine)propionate dihydrate
GEP20125681B (en) * 2008-02-19 2012-10-25 Grindex Publiska As A one-pot process for preparing 3-(2,2,2-trimethylhydrazinium) propionate dihydrate
GEP20125676B (en) * 2008-05-26 2012-10-25 Grindex Publiska As New method of 3-(2,2,2-trimethylhydrazinium) propionate dihydrate preparation
EP2128126A1 (fr) * 2008-05-26 2009-12-02 Grindeks, a joint stock company Nouveau procédé pour la préparation de dihydrate propionate 3-(2,2,2-triméthylhydrazinium)
UA101065C2 (ru) * 2008-10-29 2013-02-25 Гріндекс, Е Джоінт Сток Компані Местный препарат 3-(2,2,2-триметилгидразиний)пропионата дигидрата
LV14230B (lv) * 2009-04-30 2011-05-20 Latvijas Organiskās Sintēzes Institūts Farmaceitiska kompozīcija Parkinsona slimības profilaksei un ārstēšanai
KR20120050437A (ko) * 2009-06-25 2012-05-18 테트라, 시아 신규한 아세틸살리실산 염들
WO2010149654A1 (fr) * 2009-06-25 2010-12-29 Grindeks, A Joint Stock Company Composition pharmaceutique de gamma-butyrobétaïne ou sel pharmaceutiquement acceptable et de meldonium ou sel pharmaceutiquement acceptable
LV14274B (lv) * 2009-06-25 2011-03-20 Grindeks, A/S Meldoniju saturošs kombinēts medicīniskais produkts
LV14268B (lv) * 2009-06-25 2011-03-20 Grindeks, A/S Meldonija sukcinātu saturoši medicīniskie produkti
EP2399904A1 (fr) * 2010-05-26 2011-12-28 Nabriva Therapeutics AG Procédé de préparation de pleuromutilines
EP2420224A1 (fr) * 2010-08-11 2012-02-22 Grindeks, a joint stock company Procédé de production d'une composition pharmaceutique solide stable de dihydrate propionate 3-(2,2,2-trimethylhydrazinium)
AU2012247467B2 (en) * 2011-04-27 2016-07-28 Grindeks, A Joint Stock Company Use of 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease
RU2458690C1 (ru) * 2011-05-31 2012-08-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" Производное 3-(2,2,2-триметилгидразиний) пропионата - 5-бромникотинат 3-(2,2,2-триметилгидразиний) пропионат калия, обладающее противоишемической активностью
RU2457198C1 (ru) * 2011-05-31 2012-07-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" Производное 3-(2,2,2-триметилгидразиний)пропионата - глицинат 3-(2,2,2-триметилгидразиний)пропионат калия, обладающее противоишемической активностью
RU2467745C1 (ru) * 2011-08-08 2012-11-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" Производное 3-(2,2,2-триметилгидразиний) пропионата - 5-бромникотинат 3-(2,2,2-триметилгидразиний) пропионат калия, обладающее эндотелиопротекторной активностью
RU2467744C1 (ru) * 2011-08-08 2012-11-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" Производное 3-(2,2,2-триметилгидразиний) пропионата - 5-гидрокисиникотинат 3-(2,2,2-триметилгидразиний) пропионат калия, обладающее эндотелиопротекторной активностью
RU2485953C1 (ru) * 2012-04-12 2013-06-27 Общество с ограниченной ответственностью "Научно-внедренческий центр Агроветзащита" Комплекс 3-(2,2,2-триметилгидразиний) пропионат-2-этил-6-метил-3-гидроксипиридина дисукцинат, обладающий антигипоксическим и адаптогенным действием, и способ его получения
LV14848B (lv) * 2012-10-25 2015-06-20 Latvijas Organiskās Sintēzes Institūts Farmaceitiska kompozīcija trimetilamīna-N-oksīda līmeņa pazemināšanai
RU2527347C1 (ru) * 2013-03-12 2014-08-27 Общество с ограниченной ответственностью "Научно-внедренческий центр "Агроветзащита" Стабильная жидкая фармацевтическая композиция комплекса 3-(2,2,2-триметилгидразиний) пропионат-2-этил-6-метил-3-гидроксипиридина дисукцината, обладающая антигипоксическим, антиоксидантным и адаптогенным действием
EP2842557A1 (fr) * 2013-08-30 2015-03-04 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Mildronate dans des troubles ophtalmiques

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU997646A1 (ru) 1978-11-27 1983-02-23 Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвсср Кормова добавка
SU978808A1 (ru) * 1980-01-18 1982-12-07 Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвсср Способ регулировани роста растений люпина
SU1680693A1 (ru) * 1987-03-25 1991-09-30 Институт Органического Синтеза Ан Латвсср Этил-3-(2,2-диметил-2-этилгидразиний)пропионат иодистый, про вл ющий антиаритмическую активность
EP0307977B1 (fr) 1987-09-07 1992-09-30 Teikoku Tsushin Kogyo Co. Ltd. Boîtier en résine moulée d'une pièce électronique avec câble plat
LV11727B (en) * 1995-08-21 1997-08-20 Kalvins Ivars Pharmaceutical composition

Also Published As

Publication number Publication date
US7223797B2 (en) 2007-05-29
CA2535150C (fr) 2010-04-13
HK1093197A1 (en) 2007-02-23
DE602004011790D1 (de) 2008-03-27
SI1667960T1 (sl) 2008-08-31
WO2005012233A8 (fr) 2005-05-19
UA82540C2 (uk) 2008-04-25
PL1667960T3 (pl) 2008-06-30
EA009083B1 (ru) 2007-10-26
EP1667960A1 (fr) 2006-06-14
DE602004011790T2 (de) 2009-03-05
MXPA06000955A (es) 2006-03-30
ES2302011T3 (es) 2008-07-01
EA200600175A1 (ru) 2006-08-25
NZ545440A (en) 2009-03-31
AU2004260779A1 (en) 2005-02-10
NO20055867L (no) 2006-02-27
JP2007501222A (ja) 2007-01-25
WO2005012233A1 (fr) 2005-02-10
KR100745160B1 (ko) 2007-08-01
MA28025A1 (fr) 2006-07-03
EP1667960B1 (fr) 2008-02-13
IL173126A (en) 2011-02-28
US20060264506A1 (en) 2006-11-23
JP4634380B2 (ja) 2011-02-16
IL173126A0 (en) 2006-06-11
HRP20080192T3 (en) 2008-05-31
AU2004260779B2 (en) 2009-01-22
CA2535150A1 (fr) 2005-02-10
KR20060059995A (ko) 2006-06-02
NO334623B1 (no) 2014-04-28
PT1667960E (pt) 2008-05-02
ATE386014T1 (de) 2008-03-15

Similar Documents

Publication Publication Date Title
NO20055867L (no) Meldonium salts, method of their preparation and pharmaceutical composition on their basis
CN104230795B (zh) 吡喃酮和吡啶酮衍生物的制备方法
DK1206467T3 (da) N-heterocykliske derivater som NOS-inhibitorer
HUP0102723A2 (hu) Új difenilkarbamid-származékok, eljárás előállításukra és ezeket tartalmazó gyógyászati készítmények
DE602004009200D1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
HK1076107A1 (en) Pyrrolidine derivatives as oxytocin antagonists
HUT57740A (en) Process for producing n-arylpiperazine alkaneamide derivatives of general formula (i) and pharmaceutical compositions promoting sleep and comprising such compounds
HU194879B (en) Process for producing 1,6-naphtiridine derivatives and pharmaceutical compositions containing them
NO20032314L (no) Nye desloratadinsalter, fremgangsmåte for deres syntese og farmasöytiske preparater derav
JPH08510477A (ja) 新規なn−ベンゾイルメチル−ピペリジン類
NO20041551L (no) Substituerte alkylaminopyridazinonderivater, fremgangsmate til fremstilling derav og farmasoytisk sammensetning som inneholder dem
HK1075656A1 (en) New piperidinyl-alkylamino-pyridazinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing said compounds
NO20035026D0 (no) Dihydroimidazo [5,1-A]-<beta>-karbolinderivater, fremgangsmåte til deres fremstilling og anvendelse derav som legemiddel
NO20010802L (no) Nye aryl- eller heteroarylkinolylfosfonsyreforbindelser, en fremgangsmåte ved deres fremstilling og sammensetningerinneholdende dem
ATE338749T1 (de) Derivate von 3-phenyl-n-(2-(4-benzyl)piperidin-1- yl)ethyl) acrylamid mit ccr-3-rezeptor antagonistischer wirkung zur verwendung bei der behandlung von entzündungen und allergischen leiden
HU196159B (en) Process for producing aphidicolin derivatives and pharmaceutics comprising the same as active ingredient
WO2022243650A1 (fr) Nouveaux derives azaindole en tant qu'agents antiviraux
JPH05271220A (ja) アミン誘導体およびこれを含有する降圧剤
NO20022891L (no) Nye cykliske <alfa>-amino-<gamma>-hydroksyamidforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetningerinneholdende dem
JPS59190982A (ja) 4’−フルオロメチル−3−アミノ−2−メチル置換プロピオフエノン誘導体
KR20090005842A (ko) 신규한 카보니트릴 화합물, 이의 제조방법 및 이를포함하는 류마티스성 관절염, 골관절염, 파제트병,악성고칼슘혈증, 대사성골질환 및 각종 암의 치료 및예방을 위한 약제학적 조성물